DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells

dc.contributor.authorRozen, Esteban J.
dc.contributor.authorRoewenstrunk, Julia
dc.contributor.authorBarallobre, María José
dc.contributor.authorDi Vona, Chiara
dc.contributor.authorJung, Carole
dc.contributor.authorFigueiredo, Ana F.
dc.contributor.authorLuna Cornadó, Jeroni
dc.contributor.authorFillat i Fonts, Cristina
dc.contributor.authorArbonés de Rafael, Maria Lourdes, 1959-
dc.contributor.authorGraupera i Garcia-Milà, Mariona
dc.contributor.authorValverde, Miguel Ángel
dc.contributor.authorLuna, Susana de la
dc.date.accessioned2020-12-02T14:25:39Z
dc.date.available2020-12-02T14:25:39Z
dc.date.issued2018-01-08
dc.date.updated2020-12-02T08:16:29Z
dc.description.abstractAngiogenesis is a highly regulated process essential for organ development and maintenance, and its deregulation contributes to inflammation, cardiac disorders, and cancer. The Ca2+/nuclear factor of activated T cells (NFAT) signaling pathway is central to endothelial cell angiogenic responses, and it is activated by stimuli like vascular endothelial growth factor (VEGF) A. NFAT phosphorylation by dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) is thought to be an inactivating event. Contrary to expectations, we show that the DYRK family member DYRK1A positively regulates VEGF-dependent NFAT transcriptional responses in primary endothelial cells. DYRK1A silencing reduces intracellular Ca2+ influx in response to VEGF, which dampens NFAT activation. The effect is exerted at the level of VEGFR2 accumulation leading to impairment in PLC gamma 1 activation. Notably, Dyrk1 alpha heterozygous mice show defects in developmental retinal vascularization. Our data establish a regulatory circuit, DYRK1A/C-a2+/NFAT, to fine-tune endothelial cell proliferation and angiogenesis.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid29742440
dc.identifier.urihttps://hdl.handle.net/2445/172465
dc.language.isoeng
dc.publisherCell Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.celrep.2018.04.008
dc.relation.ispartofCell Reports, 2018, vol. 23, num. 6, Pp 1867-1878
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/675392/EU//Phd
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/317250/EU//VESSEL
dc.relation.urihttps://doi.org/10.1016/j.celrep.2018.04.008
dc.rightscc-by-nc-nd (c) Rozen et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationAngiogènesi
dc.subject.classificationCàncer
dc.subject.otherNeovascularization
dc.subject.otherCancer
dc.titleDYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Rozen.pdf
Mida:
7.12 MB
Format:
Adobe Portable Document Format